QR-kod

The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey

BackgroundAlemtuzumab (ALZ) is an immune reconstitution therapy for treating relapsing-remitting multiple sclerosis (RRMS). However, ALZ increases the risk of secondary autoimmune diseases (SADs).ObjectiveWe explored whether the detection of autoimmune antibodies (auto-Abs) could predict the develop...

Full beskrivning

Sparad:
Huvudupphov: Sofia Sandgren, Lenka Novakova, Markus Axelsson, Firoozeh Amirbeagi, Ingrid Kockum, Tomas Olsson, Clas Malmestrom, Jan Lycke
Materialtyp: Artigo
Språk:Inglês
Utgiven: Frontiers Media S.A. 2023-03-01
Serie:Frontiers in Neurology
Ämnen:
Graves' disease
secondary autoimmunity
alemtuzumab (Lemtrada)
multiple sclerosis
autoimmune antibodies
autoimmune thyroid disease (AITD)
Länkar:https://www.frontiersin.org/articles/10.3389/fneur.2023.1137665/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk